Patents by Inventor Ariko Kodaira

Ariko Kodaira has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic compounds
    Patent number: 7902179
    Abstract: A pharmaceutical composition containing a heterocyclic compound of the formula (I) wherein each symbol is as defined in the specification, an isomer thereof, a solvate thereof or a pharmaceutically acceptable salt thereof as an active ingredient has a superior TNF-? production suppressing action. Accordingly, it is useful for the prophylaxis or treatment of various diseases caused by abnormal production of TNF-?.
    Type: Grant
    Filed: April 26, 2002
    Date of Patent: March 8, 2011
    Assignee: Ajinomoto Co., Inc.
    Inventors: Yasuhiro Tanaka, Kohichi Fujita, Yoshitomo Chujoh, Syunsuke Fukuda, Yuka Ikenoue, Tomoyuki Tagami, Akira Chiba, Ariko Kodaira, Hideki Matsumoto, Tadakiyo Nakagawa, Tatsuhiro Yamada, Manabu Suzuki, Masahiro Murata
  • Benzene derivatives and pharmaceutical use thereof
    Patent number: 7459585
    Abstract: The present invention provides an AP-1 activation inhibitor, NF-kappa B activation inhibitor, inflammatory cytokine production inhibitor, matrix metalloprotease production inhibitor, inflammatory cell adhesion molecule expression inhibitor, anti-inflammatory agent, antirheumatic agent, immunosuppressant, cancer metastasis inhibitor, remedy for arteriosclerosis and antiviral agent which contain the benzene derivative of the following general formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Grant
    Filed: March 24, 2005
    Date of Patent: December 2, 2008
    Assignee: Ajinomoto Co., Inc.
    Inventors: Yukio Iino, Kohichi Fujita, Takashi Tsuji, Ariko Kodaira, Kenji Takehana, Tsuyoshi Kobayashi, Takashi Yamamoto
  • Benzene derivatives and pharmaceutical use thereof
    Publication number: 20050165114
    Abstract: The present invention provides an AP-1 activation inhibitor, NF-kappa B activation inhibitor, inflammatory cytokine production inhibitor, matrix metalloprotease production inhibitor, inflammatory cell adhesion molecule expression inhibitor, anti-inflammatory agent, antirheumatic agent, immunosuppressant, cancer metastasis inhibitor, remedy for arteriosclerosis and antiviral agent which contain the benzene derivative of the following general formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: March 24, 2005
    Publication date: July 28, 2005
    Applicant: AJINOMOTO CO. INC
    Inventors: Yukio Iino, Kohichi Fujita, Takashi Tsuji, Ariko Kodaira, Kenji Takehana, Tsuyoshi Kobayashi, Takashi Yamamoto
  • Heterocyclic compounds and medical use thereof
    Patent number: 6794378
    Abstract: The present invention provides an AP-1 activation inhibitor, a NF-kappaB activation inhibitor, an inflammatory cytokine production inhibitor, a production inhibitor for matrix metalloprotease or an inflammatory cell adhesion factor expression inhibitor, which contains a heterocyclic compound or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Grant
    Filed: December 31, 2001
    Date of Patent: September 21, 2004
    Assignee: Ajinomoto Co., Inc.
    Inventors: Yukio Iino, Koichi Fujita, Ariko Kodaira, Toshihiro Hatanaka, Kenji Takehana, Tsuyoshi Kobayashi, Atsushi Konishi, Takashi Yamamoto
  • Heterocyclic compounds
    Publication number: 20040147546
    Abstract: A pharmaceutical composition containing a heterocyclic compound of the formula (I) 1
    Type: Application
    Filed: February 24, 2004
    Publication date: July 29, 2004
    Inventors: Yasuhiro Tanaka, Kohichi Fujita, Yoshitomo Chujoh, Syunsuke Fukuda, Yuka Ikenoue, Tomoyuki Tagami, Akira Chiba, Ariko Kodaira, Hideki Matsumoto, Tadakiyo Nakagawa, Tatsuhiro Yamada, Manabu Suzuki, Masahiro Murata
  • Benzene derivatives and pharmaceutical use thereof
    Patent number: 6703379
    Abstract: The present invention provides an AP-1 activation inhibitor, NF-kappa B activation inhibitor, inflammatory cytokine production inhibitor, matrix metalloprotease production inhibitor, inflammatory cell adhesion molecule expression inhibitor, anti-inflammatory agent, antirheumatic agent, immunosuppressant, cancer metastasis inhibitor, remedy for arteriosclerosis and antiviral agent which contain the benzene derivative of the following general formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Grant
    Filed: March 12, 2001
    Date of Patent: March 9, 2004
    Assignee: Ajinomoto Co., Inc.
    Inventors: Yukio Iino, Kohichi Fujita, Takashi Tsuji, Ariko Kodaira, Kenji Takehana, Tsuyoshi Kobayashi, Takashi Yamamoto
  • Benzene derivatives and pharmaceutical use thereof
    Publication number: 20030166693
    Abstract: The present invention provides an AP-1 activation inhibitor, NF-kappa B activation inhibitor, inflammatory cytokine production inhibitor, matrix metalloprotease production inhibitor, inflammatory cell adhesion molecule expression inhibitor, anti-inflammatory agent, antirheumatic agent, immunosuppressant, cancer metastasis inhibitor, remedy for arteriosclerosis and antiviral agent which contain the benzene derivative of the following general formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: March 14, 2003
    Publication date: September 4, 2003
    Applicant: AJINOMOTO CO., INC
    Inventors: Yukio Iino, Kohichi Fujita, Takashi Tsuji, Ariko Kodaira, Kenji Takehana, Tsuyoshi Kobayashi, Takashi Yamamoto
  • Heterocyclic compounds and medical use thereof
    Publication number: 20020133005
    Abstract: The present invention provides an AP-1 activation inhibitor, a NF-kappaB activation inhibitor, an inflammatory cytokine production inhibitor, a production inhibitor for matrix metalloprotease or an inflammatory cell adhesion factor expression inhibitor, which contains a heterocyclic compound or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: December 31, 2001
    Publication date: September 19, 2002
    Applicant: AJINOMOTO CO., INC.
    Inventors: Yukio Iino, Koichi Fujita, Ariko Kodaira, Toshihiro Hatanaka, Kenji Takehana, Tsuyoshi Kobayashi, Atsushi Konishi, Takashi Yamamoto
  • Benzene derivatives and Pharmaceutical use thereof
    Publication number: 20010018441
    Abstract: The present invention provides an AP-1 activation inhibitor, NF-kappa B activation inhibitor, inflammatory cytokine production inhibitor, matrix metalloprotease production inhibitor, inflammatory cell adhesion molecule expression inhibitor, anti-inflammatory agent, antirheumatic agent, immunosuppressant, cancer metastasis inhibitor, remedy for arteriosclerosis and antiviral agent which contain the benzene derivative of the following general formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: March 12, 2001
    Publication date: August 30, 2001
    Applicant: Ajinomoto Co., Inc.
    Inventors: Yukio Iino, Kohichi Fujita, Takashi Tsuji, Ariko Kodaira, Kenji Takehana, Tsuyoshi Kobayashi, Takashi Yamamoto